06/17/2024
7:38 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:23 PM | Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:27 PM | Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:30 PM | Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:15 PM | Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:19 PM | Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:12 PM | CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/27/2024
5:31 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
12:11 PM | Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2024
7:21 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:23 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:00 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:09 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:12 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:15 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:18 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:26 PM | ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
11:15 PM | Enanta Pharmaceuticals (Filer)
| Form EFFECT | |
01/26/2024
8:11 AM | Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
4:23 PM | BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
11:25 AM | Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/11/2024
3:15 PM | Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
12/15/2023
7:08 PM | Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:16 PM | Enanta Pharmaceuticals (Subject)
Vance Terry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
7:26 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
7:29 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
7:31 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
7:17 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
7:19 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
7:22 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
7:24 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
8:24 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
8:08 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
8:11 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
8:15 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
8:19 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
8:21 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:10 PM | Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:10 PM | Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:11 PM | Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:11 PM | Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
[BUY ALERT] “This Could Be Worth 28X More than NVIDIA” (Ad) This firm's stock is currently trading for only $15.
But that won't last long.
Because even OpenAI founder Sam Altman admits AI "depends" on this firm's work. Click here for the ticker >>> |
11/22/2023
4:12 PM | Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:12 PM | Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:12 PM | Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:38 PM | Enanta Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/22/2023
3:12 PM | Enanta Pharmaceuticals (Filer)
| Form POSASR | |
11/22/2023
3:21 PM | Enanta Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/16/2023
3:31 PM | Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
Free ENTA Stock Alerts